CD44 and malignant tumor of neck: The cells were genetically stable, recapitulated genetic changes typical for LHSCCs, and expressed an epithelial cell marker (pan-keratin), as well as a head-and-neck cancer biomarker, CD44 (CD44 expression levels were higher in tumor cell lines, in comparison to normal cells).